fashion -WSS

fashion

author：entertainment 2025-09-30 02:09:28 - browse：3938

health care AI border between health care and tech — Adobe

There’s been significant investment in companies creating artificial intelligence (AI) applications for health and health care over the last decade. But while there have been successes, notably in the area of medical imaging, the industry is known more for not yet living up to its potential — think IBM Watson.

The slow pace of AI adoption in health care stems from the fact that health AI sits on the border between two large industries, health care and tech. And like the border between two nations, there are significant differences on either side.

During my career, I have spent time on each side. Now, as the CEO of a company on the border, I’ve developed a deeper understanding of the differences that create barriers to mutual innovation. For health AI to achieve its potential, health care and tech companies must keep the big picture top of mind: health care is about saving lives.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： A new study sees potential in DNA sequencing of infants

focus

explore

WSS

Why ADHD is under

Leqembi, other new Alzheimer’s drugs require better biomarkers

Petition to FDA: Get the lead out of consumer hair dyes

Addiction experts warn against a second 'war on drugs'

New research casts further doubt on a common procedure used with IVF

New research casts further doubt on a common procedure used with IVF

hotspot

fashion

focus

Psychedelics group wrestles with new pharma identity

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

At least 13 dead in Texas as scorching temps continue

Anxious about a speech? A startup wants you to pop a minty cardiac drug

After affirmative action ruling, medical educators look to 'holistic review'

Cytokinetics CEO stresses company can launch heart drug on its own

Duchenne breakthrough therapy leaves behind pioneering families

Beach reads and more: STAT's 2023 summer book list

As demand for Covid shots wanes, Moderna seeks its next success

Living with Fabry disease, a condition that causes chronic pain

knowledge

Wearables generate powerful data but its not useful to doctors, yet

Elizabeth Holmes on track for early release from her 11

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Case highlights the risks of experimental stem cell therapy

Beach reads and more: STAT's 2023 summer book list

Why 40% Americans with Parkinson’s don’t see a neurologist

focus

explore

focus

hotspot